(19 Jul 2024) China’s science and technology ministry has prohibited all clinical research involving germline genome editing, describing the approach as ‘irresponsible’.
Germline genome editing involves making edits to DNA in egg, sperm or early embryos to introduce changes that can be inherited by future generations.
The South China Morning Post reports that the new Ethical Guideline for Human Genome Editing Research are China’s latest effort to tighten regulations following the case of Chinese researcher, He Jiankui, who claimed to have created the world’s first gene-edited babies.
Find out more here.
